MYDA Advisors’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

MYDA Advisors’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-380,000	Closed	-$3.79M	–	174
2022 Q3	$3.79M	Sell	380,000 -30,000	-7%	-$298K	1.78%	13
2022 Q2	$4.05M	Hold	410,000	–	–	1.13%	15
2022 Q1	$4.03M	Hold	410,000	–	–	1.59%	13
2021 Q4	$4M	Sell	410,000 -299	-0.1%	-$2.93K	1.07%	23
2021 Q3	$4.02M	Hold	410,299	–	–	1.12%	21
2021 Q2	$4M	Buy	+410,299	New	+$4.05M	1%	20

MYDA Advisors's FLAC Position: Q4 2022 in Review

MYDA Advisors sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 380,000 shares — an estimated $3.79M sold.

MYDA Advisors first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $4.05M in Q2 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

MYDA Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
MYDA Advisors sold 380,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $3.79M.
MYDA Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
MYDA Advisors's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $4.05M in Q2 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.